COVID-19: Africa lacks readiness for vaccine rollout – WHO

0
184

The World Health Organisation has charged African countries to improve their capacity to vaccinate populations against COVID-19, warning the continent was still far from preparedness for mass immunisation.

  Disclosing this yesterday, WHO Director, Matshidiso Moeti  , in a statement during a virtual press briefing stated that Africa has to scale up its immunisation program to place the continent on a better stead to contain pandemic outbreak.

  “Planning and preparation will make or break this unprecedented endeavour,” Moeti said.

  With three Coronavirus vaccines now showing efficacy rates of 70 per cent or more, the UN body called on Africa to ramp up preparations for the continent’s largest ever immunisation drive.

READ MORE:  COVID-19: Petroleum industry to construct hospitals, diagnosis centers

  According to WHO’s report, African region is so far only 33 per cent ready to roll out COVID-19 vaccines.

  That figure, based on data provided by 40 countries on a series of readiness criteria, is well below a desired 80 per cent benchmark.

The main concerns are a lack of adequate funding plans, monitoring tools and community outreach.

  “There are key logistical and financing gaps where international solidarity will be imperative,” Moeti said.

  The WHO estimates that rolling out a COVID-19 vaccine to just priority populations in Africa will cost around $5.7 billion (4.8 billion euros).

   African countries will be partially subsidised by the COVAX global COVID-19 distribution scheme.

READ MORE:  Our people shouldn't fear COVID-19 – Survivor, Oyo gov

  The World Bank has also set aside $12 billion (10.1 billion euros) to help developing countries finance their immunisation programs.

  Moeti said the aim was to vaccinate three per cent of Africa’s population by March 2021, and 20 per cent by the end of the year.

   Other health experts at the briefing said additional research was needed to develop vaccines more suitable to the continent.

   They noted that a promising vaccine developed by Pfizer and BioNTech, which tested at a 95 per cent success rate at its latest trial, must be kept at -70 degrees Celsius, which is currently not obtainable in many African  hospitals.

READ MORE:  All Kaduna State legislators to go for COVID-19 test

  So far only Egypt, Morocco, Kenya and South Africa have active Covid-19 vaccine trials.

  Moeti said it was important for the continent not to fall behind on global preparations for COVID-19 vaccinations even though coronavirus infections had somewhat flattened.

 She noted that Africa has been relatively spared compared to the rest of the world, with over 2.1 million cases and 50,000 deaths recorded to date.

  But some countries are beginning to see localised infection surges, particularly in South Africa and the Maghreb.

  “We are starting to see an uptick and that gives us a lot of concerns. The curve is once again trending upwards a little bit.”Moeti warned.

LEAVE A REPLY

Please enter your comment!
Please enter your name here